Kelly Chin, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: United therapeutics(MODEST), Merck & Co., Inc.(MODEST), Gossamer Bio(MODEST), Janssen(MODEST), Shouti(MODEST) RESEARCH/RESEARCH GRANTS: Janssen(SIGNIFICANT), Gossamer Bio(NONE), Merck & Co., Inc.(NONE), Altavant(NONE), United Therapeutics(NONE) OTHER FINANCIAL BENEFIT: Arena(MODEST)

View Full Disclosure